Home › Ziekte van Crohn › Washington › Tacoma
Ziekte van Crohn klinische studies in Tacoma, WA
11 studies voor Ziekte van Crohn zoeken deelnemers op locaties in en rond Tacoma (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RekruterenFase 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RekruterenFase 3
- Washington Gastroenterology - Tacoma ( Site 5004), Tacoma
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruterenFase 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RekruterenFase 2
- Washington Gastroenterology - Tacoma /ID# 267302, Tacoma
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RekruterenFase 2/3
- GI Alliance Tacoma, Tacoma
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekruterenFase 3
- Washington Gastroenterology - Tacoma, Tacoma
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RekruterenFase 4
- Washington Gastroenterology- GIA, Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
RekruterenFase 3
- GI Alliance Tacoma, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
RekruterenFase 3
- MultiCare Institute for Research & Innovation, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
RekruterenFase 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RekruterenFase 2
- Mirador Therapeutics Selected Site, Tacoma
Ziekte van Crohn studies in andere steden
- New York City, NY35 studies
- Cleveland, OH19 studies
- St. Louis, MO19 studies
- Boston, MA19 studies
- Miami, FL19 studies
- Orlando, FL17 studies
- Houston, TX17 studies
- Atlanta, GA17 studies
- Tyler, TX16 studies
- San Diego, CA15 studies
- San Antonio, TX15 studies
- Los Angeles, CA15 studies
Andere studies in Tacoma
- Niet-kleincellige longkanker20 studies
- Borstkanker18 studies
- Colitis ulcerosa15 studies
- Multipel myeloom13 studies
- Prostaatkanker11 studies
- Metastatische kanker9 studies
- Colorectale kanker9 studies
- Melanoom7 studies
- Eierstokkanker7 studies
- Kanker (alle vormen)6 studies
- Aldermeesklierkanker6 studies
- Obesitas6 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.